期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
SUBJECT INDEX《CHINESE MEDICAL SCIENCES JOURNAL》Volume 27,2012
1
《Chinese Medical Sciences Journal》 CAS CSCD 2012年第4期253-260,共8页
关键词 SUBJECT INDEX Volume 27 2012 chinese medical scienceS JOURNAL
下载PDF
SUBJECT INDEX CHINESE MEDICAL SCIENCES JOURNAL Volume 22,2007
2
《Chinese Medical Sciences Journal》 CAS CSCD 2007年第4期265-274,共10页
Acute myocardial infarction Inferior-septal Myocardial Infarction Misdiagnosed as Anterior-septal Myocardial Infarction:Electrocardiographic,Scintigraphic,and Angiographic
关键词 SUBJECT INDEX chinese medical scienceS JOURNAL Volume 22 2007 WANG
下载PDF
SUBJECT INDEX CHINESE MEDICAL SCIENCES JOURNAL Volume 21,2006
3
《Chinese Medical Sciences Journal》 CAS CSCD 2006年第4期287-296,F0003,共11页
关键词 WANG SUBJECT INDEX chinese medical scienceS JOURNAL Volume 21 2006
下载PDF
SUBJECT INDEX CHINESE MEDICAL SCIENCES JOURNAL Volume 24,2009
4
《Chinese Medical Sciences Journal》 CAS CSCD 2009年第4期253-260,F0003,共9页
关键词 SUBJECT INDEX chinese medical scienceS JOURNAL Volume 24 2009 WANG
下载PDF
SUBJECT INDEX CHINESE MEDICAL SCIENCES JOURNAL Volume 23, 2008
5
《Chinese Medical Sciences Journal》 CAS CSCD 2008年第4期254-262,共9页
关键词 SUBJECT INDEX chinese medical scienceS JOURNAL Volume 23
下载PDF
SUBJECT INDEX CHINESE MEDICAL SCIENCES JOURNAL Volume20,2005
6
《Chinese Medical Sciences Journal》 CAS CSCD 2005年第4期282-292,共11页
关键词 SUBJECT INDEX chinese medical scienceS JOURNAL Volume20 2005
下载PDF
Application and mechanisms of Sanhua Decoction in the treatment of cerebral ischemia-reperfusion injury
7
作者 Ya-Kuan Wang Huang Lin +4 位作者 Shu-Rui Wang Ru-Tao Bian Yang Tong Wen-Tao Zhang Ying-Lin Cui 《World Journal of Clinical Cases》 SCIE 2024年第4期688-699,共12页
Cerebral ischemia-reperfusion is a process in which the blood supply to the brain is temporarily interrupted and subsequently restored.However,it is highly likely to lead to further aggravation of pathological damage ... Cerebral ischemia-reperfusion is a process in which the blood supply to the brain is temporarily interrupted and subsequently restored.However,it is highly likely to lead to further aggravation of pathological damage to ischemic tissues or the nervous system.,and has accordingly been a focus of extensive clinical research.As a traditional Chinese medicinal formulation,Sanhua Decoction has gradually gained importance in the treatment of cerebrovascular diseases.Its main constituents include Citrus aurantium,Magnolia officinalis,rhubarb,and Qiangwu,which are primarily used to regulate qi.In the treatment of neurological diseases,the therapeutic effects of the Sanhua Decoction are mediated via different pathways,including antioxidant,anti-inflammatory,and neurotransmitter regu-latory pathways,as well as through the protection of nerve cells and a reduction in cerebral edema.Among the studies conducted to date,many have found that the application of Sanhua Decoction in the treatment of neurological diseases has clear therapeutic effects.In addition,as a natural treatment,the Sanhua Decoction has received widespread attention,given that it is safer and more effective than traditional Western medicines.Consequently,research on the mechanisms of action and efficacy of the Sanhua Decoctions in the treatment of cerebral ischemia-reperfusion injury is of considerable significance.In this paper,we describe the pathogenesis of cerebral ischemia-reperfusion injury and review the current status of its treatment to examine the therapeutic mechanisms of action of the Sanhua Decoction.We hope that the findings of the research presented herein will contribute to a better understanding of the efficacy of this formulation in the treatment of cerebral ischemia-reperfusion,and provide a scientific basis for its application in clinical practice. 展开更多
关键词 Sanhua Decoction Cerebral ischemia-reperfusion Mechanism of action Application progress Traditional chinese medical science REVIEW
下载PDF
Radiotherapy in combination with systemic therapies for brain metastases:current status and progress 被引量:6
8
作者 Lei Liu Wanqi Chen +6 位作者 Ruopeng Zhang Yuekun Wang Penghao Liu Xin Lian Fuquan Zhang Yu Wang Wenbin Ma 《Cancer Biology & Medicine》 SCIE CAS CSCD 2020年第4期910-922,共13页
Brain metastases(BMs)are the most common cause of intracranial neoplasms in adults with poor prognosis.Most BMs originate from lung cancer,breast cancer,or melanoma.Radiotherapy(RT),including whole brain radiotherapy(... Brain metastases(BMs)are the most common cause of intracranial neoplasms in adults with poor prognosis.Most BMs originate from lung cancer,breast cancer,or melanoma.Radiotherapy(RT),including whole brain radiotherapy(WBRT)and stereotactic radiation surgery(SRS),has been widely explored and is considered a mainstay anticancer treatment for BMs.Over the past decade,the advent of novel systemic therapies has revolutionized the treatment of BMs.In this context,there is a strong rationale for using a combination of treatments based on RT,with the aim of achieving both local disease control and extracranial disease control.This review focuses on describing the latest progress in RT as well as the synergistic effects of the optimal combinations of RT and systemic treatment modalities for BMs,to provide perspectives on current treatments. 展开更多
关键词 supported by grants from Beijing Municipal Natural science Foundation(Grant No.7202150) chinese Academy of medical sciences Innovation Fund for medical sciences(Grant No.2016-I2M-2-001)
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部